ClinicalTrialsFinder

Acute Myeloid Leukemia, Refractory Clinical Trials in Baltimore, Maryland

1 recruitingBaltimore, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, Refractory
Oryzon Genomics S.A.50 enrolled13 locationsNCT05546580